CLDI

Eric E. Poma

Known title: Chief Executive OfficerCIK: 0001339484

Eric E. Poma's purchase track record

Eric E. Poma has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/21/2025CLDI$50K-18.8%-56.9%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

CLDI Included in After-Market Movers List. Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.

this person other insiders at CLDI

Transaction History

CLDI▲ Buy$50K

We use analytics to understand how market-wall is used. No personal data is sold.